ATE520987T1 - Verfahren zum nachweis und/oder screening zur überwachung eines kolorektalkrebs in einem individuum - Google Patents
Verfahren zum nachweis und/oder screening zur überwachung eines kolorektalkrebs in einem individuumInfo
- Publication number
- ATE520987T1 ATE520987T1 AT03750379T AT03750379T ATE520987T1 AT E520987 T1 ATE520987 T1 AT E520987T1 AT 03750379 T AT03750379 T AT 03750379T AT 03750379 T AT03750379 T AT 03750379T AT E520987 T1 ATE520987 T1 AT E520987T1
- Authority
- AT
- Austria
- Prior art keywords
- individual
- cancer
- screening
- detecting
- monitoring
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 238000012544 monitoring process Methods 0.000 title abstract 4
- 238000012216 screening Methods 0.000 title abstract 2
- 206010009944 Colon cancer Diseases 0.000 title 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 5
- 201000011510 cancer Diseases 0.000 abstract 5
- 102000005353 Tissue Inhibitor of Metalloproteinase-1 Human genes 0.000 abstract 1
- 108010031374 Tissue Inhibitor of Metalloproteinase-1 Proteins 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 238000013399 early diagnosis Methods 0.000 abstract 1
- 210000003608 fece Anatomy 0.000 abstract 1
- 210000003296 saliva Anatomy 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/81—Protease inhibitors
- G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- G01N2333/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200201430 | 2002-09-26 | ||
| PCT/DK2003/000634 WO2004029627A1 (en) | 2002-09-26 | 2003-09-26 | A method for detecting, screening and/or monitoring a cancer in an individual |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE520987T1 true ATE520987T1 (de) | 2011-09-15 |
Family
ID=32039055
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03750379T ATE520987T1 (de) | 2002-09-26 | 2003-09-26 | Verfahren zum nachweis und/oder screening zur überwachung eines kolorektalkrebs in einem individuum |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20060014224A1 (de) |
| EP (1) | EP1561113B1 (de) |
| JP (1) | JP2006500574A (de) |
| CN (1) | CN1685235A (de) |
| AT (1) | ATE520987T1 (de) |
| AU (1) | AU2003269837B9 (de) |
| CA (1) | CA2500232A1 (de) |
| NZ (1) | NZ539345A (de) |
| WO (1) | WO2004029627A1 (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060154245A1 (en) * | 1999-04-09 | 2006-07-13 | Rigshospitalet | Method for detecting, screening and/or montoring a cancer in individual |
| EP1619206A3 (de) * | 1999-04-09 | 2006-02-15 | Rigshospitalet | Gewebeinhibitor der Matrix-Metalproteinase Typ 1 (TIMP-1) als Krebsmarker |
| US7374886B2 (en) | 1999-04-09 | 2008-05-20 | Rigshospitalet | Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker and postoperative marker for minimal residual disease or recurrent disease in patients with a prior history of cancer |
| AU2005229492A1 (en) * | 2004-03-30 | 2005-10-13 | Rigshospitalet | Improvements in cancer treatment and cancer treatment efficacy prediction by blocking and detecting protease inhibitors |
| TW200730825A (en) * | 2005-10-21 | 2007-08-16 | Genenews Inc | Method and apparatus for correlating levels of biomarker products with disease |
| US7943328B1 (en) | 2006-03-03 | 2011-05-17 | Prometheus Laboratories Inc. | Method and system for assisting in diagnosing irritable bowel syndrome |
| US20080085524A1 (en) * | 2006-08-15 | 2008-04-10 | Prometheus Laboratories Inc. | Methods for diagnosing irritable bowel syndrome |
| US20100094560A1 (en) * | 2006-08-15 | 2010-04-15 | Prometheus Laboratories Inc. | Methods for diagnosing irritable bowel syndrome |
| KR20120087885A (ko) * | 2007-06-29 | 2012-08-07 | 안국약품 주식회사 | 난소암의 예측 마커 |
| JP2010054305A (ja) * | 2008-08-27 | 2010-03-11 | Tohoku Denshi Sangyo Kk | 癌罹病の検定に使用するデータの収集方法 |
| WO2010096674A2 (en) | 2009-02-20 | 2010-08-26 | The Regents Of The University Of California | A+ biomarker assays |
| EP3578984A3 (de) * | 2013-10-28 | 2020-03-04 | Salivatech Co., Ltd. | Speichelbiomarker für mundhöhlenkarzinom |
| CN104004840B (zh) * | 2014-05-26 | 2016-06-08 | 高新 | 用于早期筛查与诊断前列腺癌的试剂盒 |
| WO2023225723A1 (en) * | 2022-05-27 | 2023-11-30 | Griffith University | Biomarkers of fibrosis and uses therefor |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5324634A (en) * | 1992-03-31 | 1994-06-28 | The Research Foundation Of State University Of New York | Diagnostic tests measuring gelatinase/inhibitor complexes for detection of aggressive and metastatic cancer |
| JPH08136548A (ja) | 1994-11-11 | 1996-05-31 | Morinaga & Co Ltd | 泌尿器癌の診断法 |
| JPH11139947A (ja) * | 1997-11-11 | 1999-05-25 | Sunstar Inc | マトリックスメタロプロテアーゼ阻害剤含有口腔用組成物 |
| EP1619206A3 (de) * | 1999-04-09 | 2006-02-15 | Rigshospitalet | Gewebeinhibitor der Matrix-Metalproteinase Typ 1 (TIMP-1) als Krebsmarker |
| JP2004528814A (ja) * | 2000-10-13 | 2004-09-24 | チルドレンズ メディカル センター コーポレーション | 組織再構築関連状態についての非侵襲性酵素スクリーニング |
| WO2003087830A2 (en) | 2002-04-08 | 2003-10-23 | Rigshospitalet | Timp-1 as a postoperative marker for recurrent cancer |
-
2003
- 2003-09-26 AU AU2003269837A patent/AU2003269837B9/en not_active Ceased
- 2003-09-26 US US10/529,479 patent/US20060014224A1/en not_active Abandoned
- 2003-09-26 WO PCT/DK2003/000634 patent/WO2004029627A1/en active Application Filing
- 2003-09-26 AT AT03750379T patent/ATE520987T1/de not_active IP Right Cessation
- 2003-09-26 EP EP03750379A patent/EP1561113B1/de not_active Expired - Lifetime
- 2003-09-26 CN CNA038230879A patent/CN1685235A/zh active Pending
- 2003-09-26 JP JP2004538778A patent/JP2006500574A/ja active Pending
- 2003-09-26 CA CA002500232A patent/CA2500232A1/en not_active Abandoned
- 2003-09-29 NZ NZ539345A patent/NZ539345A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003269837B2 (en) | 2009-03-26 |
| AU2003269837A1 (en) | 2004-04-19 |
| AU2003269837B9 (en) | 2009-07-30 |
| US20060014224A1 (en) | 2006-01-19 |
| JP2006500574A (ja) | 2006-01-05 |
| EP1561113B1 (de) | 2011-08-17 |
| CA2500232A1 (en) | 2004-04-08 |
| NZ539345A (en) | 2008-04-30 |
| CN1685235A (zh) | 2005-10-19 |
| EP1561113A1 (de) | 2005-08-10 |
| WO2004029627A1 (en) | 2004-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE520987T1 (de) | Verfahren zum nachweis und/oder screening zur überwachung eines kolorektalkrebs in einem individuum | |
| ATE442592T1 (de) | Detektion und/oder beobachtung von synuclein- assoziierten krankheiten | |
| DE60310286D1 (de) | Vorrichtung und Verfahren zur nicht-invasiven Bestimmung der Konzentrationen von biologischen Flüssigkeiten mittels photoakustischer Spektroskopie | |
| ATE423217T1 (de) | Assays zur überwachung von krebspatienten auf grundlage der spiegel von analytenkomponenten des plasminogen-aktivator-systems in proben von körperflüssigkeiten | |
| ATE312946T1 (de) | Verfahren und vorrichtung zur bestimmung der gewebespezifität von freier dna in körperflüssigkeiten | |
| DE602004027739D1 (de) | Vorrichtung und verfahren zum sammeln von biologischen fluidproben und zur behandlung von ausgewählten komponenten | |
| Alshihri et al. | Dental age assessment of Western Saudi children and adolescents | |
| ATE419390T1 (de) | Verfahren zur diagnose von bauchspeicheldrüsenkrebs | |
| DE602006007814D1 (de) | Vorrichtung und Verfahren zum Messen der Durchgangszeit des Sauerstoffes im Blut | |
| ATE540676T1 (de) | Egfr-inhibitoren zur behandlung und diagnose von metastasierendem prostatakrebs | |
| ATE514948T1 (de) | In vitro verfahren zur diagnose von neurodegenerativen erkrankungen | |
| JP2010256190A5 (de) | ||
| DE60315715D1 (de) | Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs | |
| ATE483982T1 (de) | Liquordiagnostisches in vitro verfahren zur diagnose von demenz-erkrankungen und neuroinflammatorischen erkrankungen | |
| DE602005026665D1 (de) | Angereicherter antikörper zur detektion von mikrobakterieller infektion, verfahren zur anwendung und diagnosetest damit | |
| ATE418072T1 (de) | Verfahren zur diagnose von gebärmutterhalskrebs | |
| ATE557087T1 (de) | Verfahren und kit zum nachweis von sklerose verursachenden proliferativen erkrankungen und/oder heilmittel gegen sklerose verursachende proliferative erkrankungen sowie verfahren und kit zur identifizierung einer bei der vorbeugung und/oder behandlung von sklerose verursachenden proliferativen erkrankungen wirksamen substanz | |
| DE602005013430D1 (de) | Verwendung von asc als marker für kolorektalkarzinome | |
| ATE472611T1 (de) | Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression | |
| DE50101715D1 (de) | Verfahren zum nachweis von alpha-oxoaldehyden in vollblut, blutplasma und/oder serum eines patienten | |
| ATE494556T1 (de) | Verfahren zur diagnose von entzündungserkrankungen und infektionen mittels bestimmung von lasp-1/ lap-1 | |
| WO2004109286A3 (en) | Methods for detecting and treating cancer using podocalyxin and/or endoglycan | |
| DE502004006374D1 (de) | Verfahren und Vorrichtung zur quantitativen Analyse von Motorgeräuschen | |
| ATE494390T1 (de) | Verfahren und nukleinsäuren zur analyse von störungen der proliferation von kolonzellen | |
| DE602006007734D1 (de) | Verfahren und system zur echtzeitanalyse von biosensordaten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |